Abstract:Background: Sampling from a large cohort in order to derive a subsample that would be sufficient for statistical analysis is a frequently used method for handling large data sets in epidemiological studies with limited resources for exposure measurement. For clinical studies however, when interest is in the influence of a potential risk factor, cohort studies are often the first choice with all individuals entering the analysis. Objectives: Our aim is to close the gap between epidemiological and clinical studies with respect to design and power considerations. Schoenfeld's formula for the number of events required for a Cox' proportional hazards model is fundamental. Our objective is to compare the power of analyzing the full cohort and the power of a nested case-control and a case-cohort design. Methods: We compare formulas for power for sampling designs and cohort studies. In our data example we simultaneously apply a nested case-control design with a varying number of controls matched to each case, a case cohort design with varying subcohort size, a random subsample and a full cohort analysis. For each design we calculate the standard error for estimated regression coefficients and the mean number of distinct persons, for whom covariate information is required. Results: The formula for the power of a nested case-control design and the power of a case-cohort design is directly connected to the power of a cohort study using the well known Schoenfeld formula. The loss in precision of parameter estimates is relatively small compared to the saving in resources. Conclusions: Nested case-control and case-cohort studies, but not random subsamples yield an attractive alternative for analyzing clinical studies in the situation of a low event rate. Power calculations can be conducted straightforwardly to quantify the loss of power compared to the savings in the num-ber of patients using a sampling design instead of analyzing the full cohort.

Determining sample sizes for combined incident and prevalent cohort studies with and without follow-up

Sample size calculation for studies with grouped survival data

Analysis of Clinical Cohort Data Using Nested Case-control and Case-cohort Sampling Designs. A Powerful and Economical Tool

Sample size determination for semiparametric analysis of current status data

Sample size and power determination in joint modeling of longitudinal and survival data

Power and sample size calculation for the additive hazard model

Optimal survival analyses with prevalent and incident patients

Power and Sample Size for Dose-Finding Studies with Survival Endpoints under Model Uncertainty.

Sample Size Determination in Shared Frailty Models for Multivariate Time-to-Event Data

Subgroup detection and sample size calculation with proportional hazards regression for survival data

Sample-Size Formula for the Proportional-Hazards Regression Model

Long-term effect estimation when combining clinical trial and observational follow-up datasets

CASE-CONTROL SURVIVAL ANALYSIS WITH A GENERAL SEMIPARAMETRIC SHARED FRAILTY MODEL - A PSEUDO FULL LIKELIHOOD APPROACH

Power/sample size calculations for assessing correlates of risk in clinical efficacy trials

Power and sample size calculations. A review and computer program

Strategies for power calculations in predictive biomarker studies in survival data

Addressing an Idiosyncrasy in Estimating Survival Curves Using Double Sampling in the Presence of Self‐Selected Right Censoring

A Practical Simulation Method to Calculate Sample Size of Group Sequential Trials for Time-to-Event Data under Exponential and Weibull Distribution

Sample size estimation for heterogeneous growth curve models with attrition

The survival function NPMLE for combined right-censored and length-biased right-censored failure time data: properties and applications